Holen Sie sich die Stockscreener-App
13.56
2.95%
0.35
Schlusskurs vom Vortag:
$13.21
Offen:
$13.29
24-Stunden-Volumen:
31,542
Relative Volume:
0.29
Marktkapitalisierung:
$363.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.28%
1M Leistung:
+18.16%
6M Leistung:
+5.34%
1J Leistung:
+0.00%
1-Tages-Spanne:
$13.29
$13.91
1-Wochen-Bereich:
$12.55
$15.19
52-Wochen-Spanne:
$10.65
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Firmenname
Carlsmed Inc
Sektor
Branche
Telefon
858-295-9290
Adresse
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
13.67 | 351.29M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
185.32 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.92 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.57 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.39 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.66 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Eingeleitet | BTIG Research | Buy |
| 2025-08-18 | Eingeleitet | BofA Securities | Buy |
| 2025-08-18 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-08-18 | Eingeleitet | Truist | Buy |
Carlsmed Inc Aktie (CARL) Neueste Nachrichten
CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView
CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView
Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World
Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed Q4 Earnings Call Highlights - MarketBeat
Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI
Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill
Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com
Carlsmed (NASDAQ:CARL) Issues Quarterly Earnings Results - MarketBeat
CARL: 2025 revenue surged 86% with expanding margins and strong adoption of new spine surgery products - TradingView
CARL: 2025 revenue surged 86% with expanding margins; 2026 guidance targets $70–$75M and robust growth - TradingView
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Carlsmed, Inc. Provides Revenue Guidance for the Year 2026 - marketscreener.com
Head to Head Comparison: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed announces clinical debuts of two spinal surgery solutions - Today's Medical Developments
Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
Carlsmed Unveils Custom Cervical Plating Tech - National Today
Carlsmed Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - marketscreener.com
Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI) - Defense World
Financial Contrast: Carlsmed (CARL) and Its Competitors - Defense World
Carlsmed Announces first corra™ personalized Cervical Plating Procedure - Orthopedics This Week
Carlsmed Announces first corra personalized Cervical Plating Procedure - Bitget
Analyzing Carlsmed (CARL) & Its Competitors - Defense World
CARL Should I Buy - Intellectia AI
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to “Hold” - Defense World
Financial Review: Carlsmed (CARL) versus Its Rivals - Defense World
Critical Comparison: Carlsmed (NASDAQ:CARL) vs. TransEnterix (OTCMKTS:TRXDW) - Defense World
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times
Carlsmed completes first surgery using aprevo bilateral posterior system By Investing.com - Investing.com Canada
Carlsmed completes first surgery using aprevo bilateral posterior system - Investing.com Nigeria
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - Orthopedics This Week
Both private equity firms who control a good portion of Carlsmed, Inc. (NASDAQ:CARL) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
TD Waterhouse Canada Inc. Takes $2.03 Million Position in Carlsmed, Inc. $CARL - MarketBeat
Teacher Retirement System of Texas Purchases Shares of 175,000 Carlsmed, Inc. $CARL - MarketBeat
Financial Comparison: Carlsmed (NASDAQ:CARL) & ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World
Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance
Analyzing Carlsmed (NASDAQ:CARL) and Perspective Therapeutics (NASDAQ:CATX) - Defense World
Carlsmed (NASDAQ:CARL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
BTIG Reiterates Buy Rating on CARL, Maintains Price Target | CAR - GuruFocus
AI medtech firm Carlsmed prices $100.5M IPO - MSN
California-based Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed reports 61% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - Ortho Spine News
Finanzdaten der Carlsmed Inc-Aktie (CARL)
Es liegen keine Finanzdaten für Carlsmed Inc (CARL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Carlsmed Inc-Aktie (CARL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| B CAPITAL GROUP MANAGEMENT, L. | 10% Owner |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
| Sidow Kevin | Director |
Jul 24 '25 |
Buy |
15.00 |
13,333 |
199,995 |
59,566 |
| Mittendorff Robert II | Director |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
| ROOT JONATHAN D | Director |
Jul 24 '25 |
Buy |
15.00 |
466,666 |
6,999,990 |
483,999 |
| YOUNG PHILIP M | Director |
Jul 24 '25 |
Buy |
15.00 |
59,999 |
899,985 |
53,333 |
1.82%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):